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The aim of this article is to provide a preliminary estimate of how much CAM is evidence-based. For this purpose, I calculated the
percentage of 685 treatment/condition pairings evaluated in the “Desktop Guide to Complementary and Alternative Medicine”
whicharesupportedbysounddata.Theresultingﬁgurewas7.4%.Forarangeofreasons,itmightbeagrossover-estimate.Further
investigations into this subject are required to arrive at more representative ﬁgures.
1.Introduction
A lively discussion exists about the question as to how much
of conventional medicine might be based on sound evidence
[1]. One ﬁgure that is often cited is 15% [2]. It presents,
however, unreliable and out-dated information: the ﬁgure
can be traced back to a small survey conducted in 1960/61 of
prescribing practises of family doctors in a northern British
town, which looked toward controlling prescribing costs [3].
Other experts have published more convincing data showing
that an average of 76% of interventions are supported by
some form of compelling evidence, with an average of 37%
of interventions being supported by randomized clinical
trials (RCTs) [3]. A recent systematic review [4] of the topic
found that, in general internal medicine, over 50% [5]a n d
in psychiatry over 65% [6] of interventions are based on
positive data from RCTs.
Thediscussionabouttheevidence-baseofCAMisfarless
lively. Here I present a ﬁrst attempt to generate some data
and hopefully a constructive discussion on this potentially
important subject.
2. Methods
As a basis for my assessment, I used our own book The
Desktop Guide to Complementary and Alternative Medicine
[6]. In this book, we evaluate the research evidence from
clinical trials and systematic reviews as it pertains to any type
of CAM for a wide range of conditions (n = 46). For each
condition, we compiled a “summary of clinical evidence”
table in which the treatments are categorized according to
the “weight” and “direction” of the evidence. The “weight”
is conceptualized as a composite measure of the quantity,
quality and level of the research evidence, which refers to
the conﬁdence that can be placed on that evidence [6]. The
quantity refers to the total patient sample included in all
clinical trials—there could, for instance, be ﬁve studies with
an average of 20 patients resulting in a total sample of 100;
this would be less than a single study with a sample of 300.
The quality of the trial evidence refers to the likelihood
of bias, usually estimated with a score such as the Jadad
score [7]. The level of the evidence refers to the hierarchy
of research evidence where systematic reviews are on top
and opinion or anecdotal evidence at the bottom. The
“direction”oftheevidencesignalswhethertheeﬀectisclearly
positive, tentatively positive, uncertain, tentatively negative
orclearlynegative[6].Thebookhasafullmethodssectionto
maximize transparency and reproducibility. It describes our
assessments in more detail [6].
For the purpose of this analysis, I have simply counted
the number of treatments which obtained the maximum
“weight” and also were rated as “clearly positive” in our
“summary of clinical evidence” tables. This provided the
number of treatments that are supported by good evidence
(if one therapy was eﬀective for two indications it was
counted twice). Subsequently, this ﬁgure was put in relation
to the total number of treatment/condition pairings from all
the “summary of clinical evidence” tables in our book [6].
3. Results
Fifty-one treatments were characterized as having maximum
“weight” of evidence as well as being “clearly positive.”
The total number of treatment/condition pairings was 685.2 Evidence-Based Complementary and Alternative Medicine
Table 1: CAM treatments based on sound evidence.
Intervention Conditions
Acupuncture Nausea/vomiting induced by chemotherapy
Acupuncture Osteoarthritis
African plum Benign prostatic hyperplasia
Allium vegetables Cancer prevention
Aromatherapy/massage Cancer palliation
Biofeedback Hypertension
Biofeedback Migraine
Chondroitin Osteoarthritis
Co-enzyme Q10 Hypertension
Diet Rheumatoid arthritis
Ephedra sinica Overweight
Exercise Cancer prevention
Exercise Cancer palliation
Exercise Chronic fatigue syndrome
Exercise Depression
Exercise HIV/AIDS
Fiber Irritable bowel syndrome
Ginkgo biloba Alzheimer’s disease
Ginkgo biloba Peripheral vascular disease
Glucosamine Osteoarthritis
Green tea Cancer prevention
Group behaviour therapy Smoking cessation
Guar gum Diabetes
Guar gum Hypercholesterolemia
Hawthorn Chronic heart failure
Horse chestnut Chronic venous insuﬃciency
Hypnotherapy Labor pain
Kava Anxiety
Massage Anxiety
Melatonin Insomnia
Music therapy Anxiety
Oat Hypercholesterolemia
Padma 28 Peripheral vascular disease
Peppermint/caraway Non-ulcer dyspepsia
Phytodolor Osteoarthritis
Phytodolor Rheumatoid arthritis
Psyllium Constipation
Psyllium Diabetes
Red clover Menopause
Relaxation Anxiety
Relaxation Insomnia
Relaxation Nausea/vomiting induced by chemotherapy
S-adenosylmethionine Osteoarthritis
Saw palmetto Benign prostatic hyperplasia
Soy Hypercholesterolemia
St John’s wort Depression
Stress management HIV/AIDS
Tomato (lycopene) Cancer prevention
Vitamin C Upper respiratory tract infection (treatment)
Water immersion Labor pain
Yohimbine Erectile dysfunctionEvidence-Based Complementary and Alternative Medicine 3
Consequently, 7.4% of them were based on sound evidence.
Table 1 provides a list of these 51 treatment/condition pair-
ings.
4. Discussion
The estimate that 7.4% of CAM is based on sound evidence
may well be over-optimistic. We selected the conditions for
inclusion in our book [6] on the basis of two main criteria:
ﬁrst, the condition had to be relevant, that is, commonly
seen in primary care or frequently treated with CAM and/or
there had to be suﬃcient trial data to write a chapter. Thus,
this evidence summarized in the present article represents a
positiveselection.Hadwechosendiﬀerentconditionsforour
book, the percentage would most likely have been lower.
A glance at Table 1 furthermore informs us that several
of the included modalities, for example, exercise, group
behaviour therapy, stress management, ﬁber intake or
biofeedback, could easily be classiﬁed as conventional inter-
ventions rather than CAM. Had we excluded them, the per-
centageofevidence-basedCAMwouldhavedeclinedfurther.
Finally, several cases of “sound” evidence included in
Table 1 might need revision in the light of evidence that has
emergedsincethepublicationofourbook.Examplesinclude
saw palmetto (Serenoa repens)[ 8], glucosamine [9–12],
Ginkgo biloba [13–16] and acupuncture which, according
to recent ﬁndings, may not be more eﬃcacious than sham
acupuncture [17, 18].
Another concern is that the present analysis merely
relates to the question of how many therapies might be
supported by sound research evidence. It does not address
the question of how solidly CAM practice is evidence-based.
This would require an assessment of which treatments are
used and how often. Such a research project would be
complex but would certainly be a valuable contribution to
the literature.
Although my estimate of how much of CAM is evidence-
based draws on a critical evaluation of the available evi-
dence, it still presents a rather optimistic view. Further
investigations into this subject are required to arrive at more
representative ﬁgures.
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